Australia  

US Government Is Not Granting Hospitals Access To Coronavirus Medication

Video Credit: Wochit News - Duration: 00:37s - Published
US Government Is Not Granting Hospitals Access To Coronavirus Medication

US Government Is Not Granting Hospitals Access To Coronavirus Medication

Remdesivir, a potential coronavirus medication was approved by the FDA last week.

The emergency approval was ushered in due to the dire circumstances surrounding the coronavirus pandemic.

Now, some hospitals are struggling to find the drug for their patients.

According to Business Insider, the US government is deciding which hospitals get the drug and which don't.

The government is also controlling how much medication a hospital can get.

0
shares
ShareTweetSavePostSend
 

πŸ’‘ One News Page Knowledge: Other News Mentions

Remdesivir Remdesivir Antiviral drug

Remdesivir becomes first COVID-19 drug put forward for use in the EU [Video]

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Credit: Euronews English    Duration: 00:34Published
FDA Warns Against Combining Remdesivir And Hydroxychloroquine [Video]

FDA Warns Against Combining Remdesivir And Hydroxychloroquine

The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19. The warning cautions against administering hydroxychloroquine in combination with remdesivir. According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir. Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.

Credit: Wochit News    Duration: 00:31Published
Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission' [Video]

Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission'

Coronavirus cases in India have crossed over 2.8 lakh. The country witnessed the highest single-day spike of 9,996 more cases in last 24 hours. In a single day, as many as 357 deaths were reported making the total toll to 8102. Out of the total number of cases, 1,37,448 are active while 1,41,029 have been cured. In Maharashtra, coronavirus cases reached 94,041 including 46,086 active cases and 3,438 deaths which are highest in the country. Indian Council of Medical Research informed that there is no 'community transmission' of COVID-19 in India. Earlier on June 11, Lav Agarwal, Joint Secretary, Health Ministry, said that India's recovery rate is 49.21 per cent. A total of 52,13,140 samples have been tested in the country, including 1,51,808 in the last 24 hours, according to ICMR. One new case of COVID-19 reported in ITBP in the last 24 hours. Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.

Credit: ANI    Duration: 01:51Published
Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment [Video]

Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment

Health Secretary Matt Hancock announced plans for a new trial of drug Remdesivir, a treatment originally developed to fight Ebola, which appears to shorten recovery time for people with Covid-19.

Credit: PA - Press Association STUDIO    Duration: 00:43Published

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

Too soon to say if RNC will be safe -U.S. official [Video]

Too soon to say if RNC will be safe -U.S. official

Stephen Hahn, the Food and Drug Administration commissioner, said on Sunday it was "too early to tell" if it would be safe for people to attend August's Republican National Convention in Jacksonville, Florida. This report produced by Chris Dignam.

Credit: Reuters Studio    Duration: 01:43Published
FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim [Video]

FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim

The commissioner of the US Food and Drug Administration on Sunday didn't defend a claim recently made by President Donald Trump. But according to CNN, he didn't support it, either. Dr. Stephen Hahn is a member of the White House coronavirus task force. At a White House Independence Day event on Saturday, Trump made an unfounded claim that 99% of coronavirus cases are 'totally harmless.' In a CNN interview with Dana Bash on Sunday, Dr.

Credit: Wochit News    Duration: 00:45Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.

Credit: Wochit News    Duration: 00:35Published
Former FDA head says 'exponential' rise in COVID-19 possible [Video]

Former FDA head says 'exponential' rise in COVID-19 possible

Former Food and Drug Administration Commissioner Scott Gottlieb on Sunday warned that some U.S. states, including Texas, Florida and Arizona, could start to see an 'exponential' rise in COVID-19 cases this coming week. This report produced by Yahaira Jacquez.

Credit: Reuters - Politics    Duration: 01:40Published

Business Insider Business Insider Financial and business news website published by Insider Inc.

Fauci Says Trump's Wrong About Coronavirus [Video]

Fauci Says Trump's Wrong About Coronavirus

President Donald Trump said "99%" of coronavirus cases in the US are "totally harmless." Dr. Anthony Fauci is the nation's top infectious-disease expert. Fauci said Trump's claim is "false." "I'm trying to figure out where the president got that number," Fauci said in a Financial Times interview published Friday. Business Insider reports that there is overwhelming evidence of COVID-19's effects contradicts Trump's statement.

Credit: Wochit News    Duration: 00:32Published
Walgreens Puts Stock Buybacks On Hold [Video]

Walgreens Puts Stock Buybacks On Hold

Business Insider reports that Walgreens has halted its share buyback program. The pharmacy chain revealed it plans to cut 4,000 jobs after reporting worse-than-expected third-quarter figures. The drugstore giant lost $1.95 per share over the period. Thats $1.71 billion overall. The company's Boots UK division saw same-store sales nosedive 48% over the period. The reason? Walgreens says quarantine orders "compelled consumers to consolidate shopping into grocers.

Credit: Wochit News    Duration: 00:41Published
Netflix Predicted To Go Up 32% [Video]

Netflix Predicted To Go Up 32%

Netflix is on the verge of reporting a blockbuster second quarter earnings report, according to Goldman Sachs. Business Insider reports that Goldman Sachs is basing their judgement on strong app download trends On Friday, Goldman raised its Netflix price target to $670, representing upside potential of 32% from Thursday's close. The firm said COVID-19 continues to accelerate the trend towards video streaming services. Goldman Sachs said Netflix is a prime beneficiary of that trend.

Credit: Wochit News    Duration: 00:46Published
Chelsea Clinton To Open Venture Capital Firm [Video]

Chelsea Clinton To Open Venture Capital Firm

Business Insider reports that Chelsea Clinton is forming her own venture capital firm. The firm will be called Metrodora Ventures. It was registered in April and has its own Twitter account. Clinton hasn't decided whether to commit to the firm full-time, Axios reports. On Twitter, Metrodora Ventures describes itself as "a values conscious venture capital firm focused on health and learning businesses.

Credit: Wochit News    Duration: 00:33Published
Walmart is competing with Amazon Prime by launching a new subscription service [Video]

Walmart is competing with Amazon Prime by launching a new subscription service

Business Insider reports that Walmart is set to launch Walmart+ by the end of this month. The subscription will cost $98 a year. It will offer members free same-day delivery from Walmart stores. Members will also get delivery perks, discounts at Walmart gas stations, early access to promotions, and self-checkout tools. The retailer will also introduce a Walmart+ branded credit card and possibly video entertainment.

Credit: Wochit News    Duration: 00:33Published

You Might Like


Tweets about this